Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184.

FDA Device Recall #Z-1075-2024 — Class II — January 8, 2024

Recall Summary

Recall Number Z-1075-2024
Classification Class II — Moderate risk
Date Initiated January 8, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Microbiologics Inc
Location Saint Cloud, MN
Product Type Devices
Quantity 580 packages

Product Description

Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184.

Reason for Recall

The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.

Distribution Pattern

US Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, MA, MI, MN, MO, MS, MT, NE, NH, NJ, NY, OH, PA, RI, TN, TX, VA, WA, WI, WV, and WY. There was government distribution and no military distribution. Foreign distribution was made to France.

Lot / Code Information

Lot #8184-68, Exp. 5/31/2025, UDI-DI 70845357041448. UPDATE: The recall was expanded on 1/23/2024 to include the following additional lot numbers: 8184-65, exp. 3/31/2025; 8184-66, exp. 4/30/2025; 8184-67, exp. 5/31/2025; 8184-69, exp. 6/30/2025; 8184-70, exp. 8/31/2025; and 8184-71, exp. 8/31/2025.

Other Recalls from Microbiologics Inc

Recall # Classification Product Date
Z-0986-2026 Class II LYFO DISK, Campylobacter jejuni subsp. jejuni d... Dec 2, 2025
Z-0984-2026 Class II KWIK-STIK 2-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0985-2026 Class II KWIK-STIK 6-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0876-2026 Class II KWIK-STIK, Quality control kit for culture medi... Nov 13, 2025
Z-2194-2025 Class II LYFO-DISK, M. Canis Derived from ATCC 36299, pa... Jun 27, 2025

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.